NEW YORK (360Dx) – BGN Technologies today announced a collaboration with Singapore medical diagnostics firm Biosensorix to develop quantitative point-of-care diagnostics.

The technology is an electrochemical lateral flow immunosensor test that can quantitatively diagnose disease-related biomarkers and pathogens. The device will be similar to a USB drive, BGN, the technology transfer company of Ben-Gurion University of the Negev, said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
14

In this webinar, Dr. Wendy Béguelin of Weill Cornell Medicine will discuss how she used the BD Rhapsody single-cell RNA-seq platform and YFP floxed reporter mouse models to study how lymphoma-associated mutations disrupt the immune system by affecting GC B-cell states, explaining the biology of initiation of low-grade follicular lymphoma.